SOPHiA GENETICS SA Net Income 2020-2024 | SOPH
SOPHiA GENETICS SA net income from 2020 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| SOPHiA GENETICS SA Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $-62 |
| 2023 | $-79 |
| 2022 | $-87 |
| 2021 | $-74 |
| 2020 | $-39 |
| 2019 | $-34 |
| SOPHiA GENETICS SA Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-15 |
| 2024-09-30 | $-18 |
| 2024-06-30 | $-15 |
| 2024-03-31 | $-14 |
| 2023-12-31 | $-24 |
| 2023-09-30 | $-14 |
| 2023-06-30 | $-21 |
| 2023-03-31 | $-20 |
| 2022-12-31 | $-14 |
| 2022-09-30 | $-23 |
| 2022-06-30 | $-25 |
| 2022-03-31 | $-25 |
| 2021-12-31 | $-21 |
| 2021-09-30 | $-21 |
| 2021-06-30 | $-18 |
| 2021-03-31 | $-13 |
| 2020-12-31 | $-10 |
| 2020-09-30 | $-10 |
| 2020-06-30 | $-8 |
| 2020-03-31 | $-11 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.203B | $0.065B |
| SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.020B | 52.51 |
| Tempus AI (TEM) | United States | $8.898B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $7.354B | 118.21 |
| Inspire Medical Systems (INSP) | United States | $4.713B | 91.55 |
| IRhythm Technologies (IRTC) | United States | $3.412B | 0.00 |
| Privia Health (PRVA) | United States | $2.848B | 213.46 |
| Enovis (ENOV) | United States | $1.975B | 12.22 |
| Schrodinger (SDGR) | United States | $1.872B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.737B | 0.00 |
| Phreesia (PHR) | United States | $1.467B | 0.00 |
| Omnicell (OMCL) | United States | $1.464B | 31.58 |
| Azenta (AZTA) | United States | $1.204B | 56.04 |
| 10x Genomics (TXG) | United States | $1.011B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.536B | 0.00 |
| Talkspace (TALK) | United States | $0.517B | 307.00 |
| Veradigm (MDRX) | United States | $0.460B | 0.00 |
| Standard BioTools (LAB) | United States | $0.421B | 0.00 |
| TruBridge (TBRG) | United States | $0.389B | 0.00 |
| Claritev (CTEV) | United States | $0.363B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.277B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.209B | 0.00 |
| Pulmonx (LUNG) | United States | $0.194B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.092B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.085B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.082B | 0.00 |
| CareCloud (CCLD) | United States | $0.077B | 3.33 |
| 111 (YI) | China | $0.071B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.059B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Outset Medical (OM) | United States | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |